Pediatrix Medical Group, Inc. $MD Stock Holdings Increased by Public Sector Pension Investment Board

Public Sector Pension Investment Board grew its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 27.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 268,076 shares of the company's stock after purchasing an additional 57,463 shares during the quarter. Public Sector Pension Investment Board owned 0.31% of Pediatrix Medical Group worth $3,884,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of MD. Nuveen LLC acquired a new position in shares of Pediatrix Medical Group during the first quarter worth about $8,024,000. Oberweis Asset Management Inc. acquired a new position in shares of Pediatrix Medical Group during the fourth quarter worth about $6,122,000. Nomura Holdings Inc. acquired a new position in shares of Pediatrix Medical Group during the fourth quarter worth about $3,882,000. Nuveen Asset Management LLC lifted its stake in shares of Pediatrix Medical Group by 110.8% during the fourth quarter. Nuveen Asset Management LLC now owns 485,587 shares of the company's stock worth $6,371,000 after purchasing an additional 255,273 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of Pediatrix Medical Group during the fourth quarter worth about $3,066,000. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Stock Up 3.9%

Pediatrix Medical Group stock traded up $0.63 during midday trading on Friday, hitting $16.78. The stock had a trading volume of 237,936 shares, compared to its average volume of 748,836. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. The stock has a market cap of $1.46 billion, a P/E ratio of 13.09 and a beta of 1.21. Pediatrix Medical Group, Inc. has a 12 month low of $10.06 and a 12 month high of $17.67. The business has a fifty day moving average price of $13.70 and a 200 day moving average price of $13.91.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.11. The firm had revenue of $468.84 million during the quarter, compared to analyst estimates of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.Pediatrix Medical Group's quarterly revenue was down 7.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.34 earnings per share. Research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analysts Forecast Growth

MD has been the topic of a number of analyst reports. UBS Group lifted their target price on Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research report on Thursday, August 14th. Zacks Research raised Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. Finally, Macquarie lifted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $16.75.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.